Network biology meets
drug discovery
We engineer medicine based not on a single target, but the biological network as a whole.
+250k
Chemotranscriptomes
Generated
Generated
+2.3B
mRNAs Measured
3
Drug Programs in
the Pipeline
the Pipeline
![](https://cdn.prod.website-files.com/65608c8c206ee41e5ab7e0e9/65f06e9a9238dcea99a55818_GettyImages-605765911.webp)
Our Technology
Chemotranscriptomes
Arpeggio is developing the world's fastest platform for transcriptomic sequencing to learn how chemistry maps to network biology.
![](https://cdn.prod.website-files.com/65608c8c206ee41e5ab7e0e9/65f06e9a9031452e77417270_GettyImages-1031213660.webp)
Our Pipeline
Chronic disease
99.5% of adults over fifty will have a chronic disease by 2040. We're working on developing a pipeline of potential drugs to tackle drug resistance in cancer, chronic kidney disease, and neurodegeneration.